Latest filing: Sun Pharma Advanced Research Company Ltd - 532872 - Intimation For Receipt Of Requests For Reclassification Of Shareholder Category
ObservedCompany dossier
Sun Pharma Advanced Research Co
NSE:SPARC · ISIN INE232I01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sun Pharma Advanced Research Co
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹14.9 Cr · PAT ₹-79.5 Cr.
Exchange XBRLLatest ownership: promoter group 65.67% and public 34.33% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Sun Pharma Advanced Research Company Ltd - 532872 - Intimation For Receipt Of Requests For Reclassification Of Shareholder Category
BSE · exchange filing
Observed
Source filing Updates - Sun Pharma Advanced Research Company Limited
NSE · exchange filing
Observed
Archived filing Copy of Newspaper Publication - Sun Pharma Advanced Research Company Limited
NSE · exchange filing
Observed
Source filing Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹14.9 Cr
- Profit after tax
- ₹-79.5 Cr
- EPS
- ₹-2.45
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 65.67%
- Public
- 34.33%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL